The power of single-cell RNA sequencing (scRNA-seq) stems from its ability to uncover cell typedependent phenotypes, which rests on the accuracy of cell type identification. However, resolving cell types within and, thus, comparison of scRNA-seq data across conditions is challenging owing to technical factors such as sparsity, low number of cells, and batch effect. To address these challenges, we developed scID (Single Cell IDentification), which uses the Fisher's Linear Discriminant Analysislike framework to identify transcriptionally related cell types between scRNA-seq datasets. We demonstrate the accuracy and performance of scID relative to existing methods on several published datasets. By increasing power to identify transcriptionally similar cell types across datasets with batch effect, scID enhances investigator's ability to integrate and uncover development-, disease-, and perturbation-associated changes in scRNA-seq data. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
HIGHLIGHTS scID identifies transcriptionally equivalent cell populations across datasets scID's accuracy relies on the goodness of cluster enriched genes in the reference scID can also be used to score data against a userprovided gene list R package and use cases are at https://github.com/ BatadaLab/scID INTRODUCTION Single-cell RNA-sequencing (scRNA-seq) (Hashimshony et al., 2012; Jaitin et al., 2014; Macosko et al., 2015; Ramskold et al., 2012; Zheng et al., 2017) is now being routinely used to characterize celltype-specific changes in development, disease, and perturbations (Regev et al., 2017) , which require analysis of cross-data comparison . However, there are technical and biological variations between the different datasets that may hamper the joint analysis of these data Kiselev et al., 2019) .
Batch correction approaches such as canonical correlation analysis (CCA) , mutual nearest neighbours (MNN) , and single cell variational inference (scVI) (Lopez et al., 2018) have been designed to integrate scRNA-seq datasets. The advantage of these methods is that batch correction allows merging of datasets that provide more power to resolve cell types (Heimberg et al., 2016) , particularly those that are rare. In both CCA and MNN, cells that have similar local correlation or neighborhood structure in the datasets are paired. However, when the data are significantly imbalanced in the number of cells and library size per cell, both of which influence accuracy of clustering, it is unclear how these methods perform. Moreover, depending on the extent of technical bias or extent of overlap in cell types between the data, untangling technical from biological variation between data may not be possible and runs the risk of over-correcting, i.e., the biological variance between the data may be lost.
As deeply characterized, extensively validated, and annotated tissue-, organ-, and organism-level atlases are increasingly being generated (Regev et al., 2017) , it is worthwhile to reuse such high-quality information to identify known populations of cells in the target data with lower quality. In addition to the propagation of cell labels and metadata across datasets, reference data can also be used to group cells in the target data in which unsupervised clustering does not resolve consistently given the partial knowledge of the cell types in the literature or with the clusters found in the superior quality reference data. In such cases, a biomarker-based approach for identifying transcriptionally equivalent cells across datasets involves determining whether the top marker genes derived from the reference clusters are present in the target cells. However, this biomarker-based approach does not work effectively owing to the dropout problem with scRNA-seq data, i.e., for a large proportion of genes, the expression values are not sampled (Bacher and Kendziorski, 2016; Stegle et al., 2015; Vallejos et al., 2017) . To map cells from target scRNA-seq data to a reference data, scmap extracts features from each reference cluster and uses a distance-and correlation-based metric to quantify the closeness between each reference cluster's centroid and the cell in the target data to assign target cells to reference clusters. However, distance metrics in high-dimensional space may not work as expected (Aggarwal et al., 2001) .
RESULTS

Identification of Transcriptionally Similar Cells across scRNA-Seq Datasets
Identifying target cells g j0 s that match a reference cluster (C) can be seen as a binary classification problem f C (g j ) by treating the reference cluster of interest as one class (C) and the rest of the reference clusters as another class (C À ), i.e., f C ðg j Þ˛fC; C À g. Assuming that cell types can be linearly separable, one can, for example, use Fisher's linear discriminant analysis to learn a direction, w C = ðw C 1 ; w C 2 ;
.; w C k C Þ, from the reference data that maximizes the separation between C and C À population where k C is the number of signature genes or features for cluster C. Thus, to each target cell we can assign an 'scID score'':
whereg j i is the normalized gene expression of feature i in cell j and w C i is the weight that reflects the discriminatory power of the i-th gene, such that in the projected space, the C and the C À populations are maximally separated. To mitigate the influence of batch effect, it may be more suitable to estimate weights from the target data instead of the reference. Given putative c and c À populations selected from the target data, the weights are estimated as
where m c i ðm c À i Þ represents the mean expression of the putative target cluster c (c À ) and s c i (s c i ) represents standard deviation of gene expression within the putative target cluster c (c À ). A target cell can then be assigned to the reference cluster C by choosing a suitable threshold. scID maps cells in the target data that are equivalent to clusters in the reference data in three key stages ( Figure 1A ).
In the first stage, genes that are differentially expressed in each cluster (herein referred to as gene signatures) are extracted from each cluster of the reference data. In the second stage, for each reference cluster C, the weights of the genes in the respective gene signature (which reflect their discriminability) are estimated either from the reference or from the target data, depending on the nature of the data, by identifying putative c and c À cells using an approach we term differential precision-recall (DPR). In the last stage, the extracted features (i.e., the combination of gene signatures and their weights) are used to identify target cells that are most concordant with extracted features. A finite mixture of Gaussians is used to model the scores of the target cells. Cells with high likelihood of falling under the distribution with the highest average score are assigned to the reference cluster from which the gene signatures were extracted. Ideally a target cell should be assigned to only one reference cluster but when closely related cells are present in the reference data, it is possible that the features extracted are not able to highly discriminate between them leading to assignment of a cell to multiple clusters in the reference. Conflicts in assignments are resolved using a relative normalized score strategy. Further details are provided below and in the Methods section.
As the accuracy of weights depends strongly on selection of true cells, we assessed the accuracy with which the DPR approach identified true cells in several published reference data. We observed that the median true-positive rate of the DPR approach was between 45% and 80% and the median false-positive rate was between 0% and 5% ( Figure 1B) . Moreover, the estimated weights after the DPR approach were consistent with weights from the reference data using published label ( Figure S1 ). Thus, although the DPR approach is stringent and misses higher-than-desired levels of true cells, its role in the overall scID methodology is the recovery of true cells with very low false-positive rate so that the estimated gene weights are accurate. To assess the accuracy of the scoring approach (stage 3 of scID) and to quantify its contribution to the improvement in classification accuracy, we used the mouse retinal bipolar DropSeq data ) and compared the true-positive and false-positive rates of cells classified by the DPR approach to the subsequent weight-based classification. We find that, relative to the accuracy of the DPR approach ( Figure 1B) , the accuracy of the weight-based classification of cells has a significantly higher true-positive rate without increase in the false-positive rate ( Figure 1C ). To assess the stability and generalizability of scID across scRNA-seq data across a range of quality and cell type composition, we performed self-mapping (i.e., using the same dataset as reference and target) of four published datasets spanning different tissues and technologies. The accuracy of self-mapping, as assessed by Adjusted Rand Index, was relatively high ( Figure 1D) . The three main stages involved in mapping cells across scRNA-seq data with scID are as follows: In stage 1, gene signatures are extracted from the reference data (shown as clustered groups on a reduced dimension). In stage 2, discriminative weights are estimated from the target data for each reference cluster-specific gene signature. In stage 3, every target cell is scored for each feature and is assigned to the corresponding reference cluster. (B) Quantification of accuracy of DPR classification (stage 2 of scID). Boxplot shows interquartile range for TPR (black) or FPR (white) for all the cell types in each published dataset listed in the x axis. See also Figure S1 . (C) Quantification of TPR and FPR of stage 2 (black) and stage 3 (white) of scID. Significance was computed using two-sided paired Kruskal-Wallis test for difference in TPR or FPR between stage 2 and stage 3.
(D) Assessment of accuracy of scID via self-mapping of published datasets. The indicated published data (x axis labels) were self-mapped, i.e., used as both reference and target, by scID and the assigned labels were compared with the published cell labels.
(E) Assessment of classification accuracy of scRNA-seq data integration. Human pancreas Smart-seq2 data (Segerstolpe et al.) were used as reference and CEL-seq1 as target (white; or CEL-seq2 as target (black; . See also Figures S2 and S3 .
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We next tested our assumption that different target data with different batch effect lead to different gene weights and quantified its impact on classification accuracy. We selected two reference-target pairs from similar tissue so that the differences are largely due to technical factors rather than biological factors. To this end, we sought to detect equivalent cells across multiple human pancreas datasets from different technologies (Smart-Seq2 , CEL-Seq1 [Baron et al., 2016] , and CEL-Seq2 ) in which the published cell identity labels for each dataset is available. We used the Smart-Seq2 as reference data and CEL-Seq or CEL-Seq2 as target. We confirmed that the two reference/target data pairs (i.e., Smart-Seq2/CEL-Seq1 and Smart-Seq2/CEL-Seq2) had different extent of batch effect ( Figure S2 ). As expected, the scID estimated weights of the same cell-type-specific genes calculated from the two target datasets are significantly different, yet the overall accuracy of cell type classification for the two target datasets by scID were similar ( Figure S3 ). scID was one of the two most accurately and consistently well-performing methods ( Figure 1E ).
However, these datasets were relatively balanced in terms of cell number and quality and therefore with mild batch effect. We next assessed these methods in dataset pairs with significant asymmetry in cell number and cell coverage between reference and target datasets in cell number and coverage and have stronger batch effect ) ( Figure S2 ).
Reference-Based Identification of Equivalent Cells by scID across the Mouse Retinal Bipolar Neurons scRNA-Seq Datasets
In general, a large number of cells despite shallow coverage per cell provides more power to resolve highly similar cells than low number of cells with deep coverage per cell (Heimberg et al., 2016) . We sought to identify equivalent cell types in scRNA-seq data with strong imbalance in the number of cells or read coverage per cell. Shekhar et al ) generated scRNA-seq data from mouse retinal bipolar neurons using two different technologies: Drop-seq (Macosko et al., 2015) (with $26,800 cells and $700 genes per cell) and the plate-based Smart-seq2 (with 288 cells and $5,000 genes per cell). Unsupervised clustering of the full Dropseq data with Seurat resulted in $18 discrete clusters, whereas unsupervised clustering of the Smart-seq2 data with Seurat and several other clustering methods (data not shown) identified only 4 clusters ( Figure 2A ) possibly due to low cell numbers.
To determine how the transcriptional signatures of the reference clusters are distributed in the target data, we computed the average gene signature per cluster ( Figure 2B ; see Methods). The dominant diagonal pattern in the gene signature matrix for the reference data indicates the specificity of the extracted gene signatures. All the subtypes of bipolar cells (BCs) that were well separated in the reference Dropseq data co-clustered in the target Smart-seq data ( Figure 2B) . Surprisingly, despite over seven times greater number of genes per cell in the target Smart-seq2 data compared with the reference Drop-seq data, the biomarker approach of using top markers of clusters from the reference Drop-seq data resulted in unambiguous assignment of only a small proportion of cells ( Figure 2C ).
Thus, we assessed the ability of scID and competing methods to assign cluster identity to cells in the target Smart-seq2 data using Drop-seq data as reference. scID and CaSTLe assigned 100% (n = 288) of the Smart-seq2 cells into 15 Drop-seq clusters, whereas scmap assigned only 63.2% (n = 182) of the Smart-seq2 cells into 10 clusters. Using target cells that specifically expressed cell-type-specific markers (yellow, Figure 2C ) as ground truth, two independent metrics for accuracy suggested that scID was one of the two most accurately performing methods on these datasets ( Figures 2D and 2E ).
Reference-Based Identification of Equivalent Cells in scRNA-Seq and Ultra-Sparse Single Nuclei RNA-Seq from Mouse Brain In many clinical settings where only postmortem tissues are available, single nuclei-RNA seq (snRNA-seq) (Habib et al., 2017; Lake et al., 2016 ) may be possible. However, the transcript abundance in the nuclei is significantly lower than in the cytoplasm and as a consequence the complexity of scRNA-seq libraries from nuclei-scRNAseq from the same tissue is significantly lower than in whole-cell scRNA-seq (Habib et al., 2017) thus making it challenging to cluster despite large number of cells. To assess how well scID performs compared with alternatives in this setting, we obtained publicly available Chromium 10X (Zheng et al., 2017 ) -based scRNA-seq data on mouse brain cells and snRNA-seq on mouse brain nuclei (see Methods).
The brain whole-cell scRNA-seq data had $9K cells, and the brain nuclei snRNA-seq data had $1K cells. Unsupervised clustering of the data separately identified different number of clusters, which did not have an obvious one-to-one correspondence ( Figure 3A ). As the whole-cell scRNA-seq data have more cells than the nuclei-seq, we used the former as reference and obtained gene sets that are differentially expressed in each cluster compared with the rest of the cells ( Figure 3B ). Efforts to identify cluster membership of nuclei-seq data based on top markers in each of the clusters from the whole-cell scRNAseq data allowed unambiguous classification of only a small number of cells possibly due to shallow coverage that leads to low dynamic range in gene expression. Not surprisingly, there was significant number of orphan cells (i.e., those in which transcripts of cell markers were not captured) ( Figure 3C ).
Thus, we assessed the ability of scID and competing methods to assign cluster identity to cells in the target (snRNA-seq) data using scRNA-seq data as reference. scID assigned 99.5% (n = 949) of the snRNA-seq cells into 14 scRNA-seq clusters, whereas scmap assigned 60.2% (n = 574) of the snRNA-seq cells into 11 clusters and CaSTLe assigned 100% (n = 954) of the snRNA-seq cells into 15 clusters. Using target cells that specifically expressed cell-type-specific markers (yellow, Figure 2C ) as ground truth, two independent metrics for accuracy suggested that scID had the highest accuracy ( Figures 3D and 3E) . (C) Identification of target (Smart-seq2) cells that are equivalent to reference (Drop-seq) clusters using marker-based approach. The top two differentially enriched (or marker) genes in each reference (Drop-seq) cluster were used to identify equivalent cells in the target (Smart-seq2) data using a thresholding approach. Bars represent percentage of classified and unassigned cells using various thresholds for normalized gene expression of the marker genes as indicated on the x axis. Gray represents the percentage of cells that express markers of multiple clusters, yellow represents the percentage of cells that can be unambiguously classified to a single cluster, and blue represents the percentage of cells that do not express markers of any of the clusters. These cells are referred to as orphans. X axis represents different thresholds of normalized gene expression (see Methods). (D) Assessment of accuracy of various methods methods for classifying target cells using Adjusted Rand Index. (E) Assessment of accuracy of various methods methods for classifying target cells using Variation of Information.
DISCUSSION
Comparison of multiple scRNA-seq datasets across different tissues, individuals, and perturbations is necessary in order to reveal potential biological mechanisms underlying phenotypic diversity. However, comparison of scRNA-seq datasets is challenging because even scRNA-seq data from the same tissue but with different technology or donor can have significant batch effect confounding the technical with the biological variability. scRNA-seq datasets generated from different scRNA-seq methods and quality (i.e., similar number of cells and library depth per cell) are in general much easier to correct than data generated from different methods and quality. Particularly, in cases of strong asymmetry in quality between datasets to be compared, mapping target cells across data at the individual cell level rather than performing batch correction can be a more appropriate route for identifying known transcriptionally related cells.
We have developed scID that uses the framework of Fisher's linear discriminant analysis to map cells from a target data to a reference dataset ( Figure 1A) . scID adapts to characteristics of the target data in order to learn the discriminative power of cluster-specific genes extracted from the reference in the target data. scID down-weighs the genes within the signature that are not discriminatory in the target data. Through extensive characterization of multiple published scRNA-seq datasets, we assessed scID's accuracy relative to alternative approaches in situations where the reference and target datasets )   R0  R1  R2  R4  R5  R6  R7  R8  R9  R10  R11  R12  R13  R14  R3   R0  R1  R2  R3  R4  R5  R6  R7  R8  R9  R10  R11  R12  R13  R14 Reference gene signatures Target clusters (uncorrected)   T0  T1  T2  T3  T4  T5  T6  T7  T8   0 have strong asymmetry in quality and have shown that scID outperforms existing methods for recovering transcriptionally related cell populations from the target data, which does not cluster concordantly with the reference.
As the scale of single-cell RNA-seq data increases and the numbers of clusters obtained are so large that manual annotation is cumbersome, scID can enable automatic propagation of annotations and metadata across clusters in these datasets. In addition, scID can be used for ordering single transcriptomes based on an arbitrary user-specified gene list without the need for providing information on gene expression levels.
Limitations of the Study
scID can estimate gene signature weights from either the reference or the target data. When the reference and the target data have strong batch effect, estimation of weights from the target appears to be more accurate. However, in cases where there are very similar cell types in the datasets to be compared, estimation of weights from the reference may be more suitable. Moreover, if the target data contain a cell type that is only weakly related to but not exactly the cell type in the reference, scID is susceptible to falsely classifying such cells.
Owing to reliance on gene signatures to discriminate between clusters, a limitation of scID is that it works only for reference clusters that have distinct gene signatures. Additionally, the accuracy of scID depends on the correctness of the labels of the reference data. For a dataset to serve as a reference, we expect well-defined clusters by cell type such that cluster-specific gene signatures exist and they are mutually exclusive as seen in Figures 2B and 3B . If neither of the two data is well clustered and contains good gene signatures, scID is not a recommended approach for identification of equivalent cell types. Imputation of gene expression (Zhang et al., 2019) particularly when the target scRNA-seq is highly shallow may increase the power for identification of equivalent cells and is worth exploring in the future.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
No datasets were generated. The R implementation for scID is available on Github (https://batadalab. github.io/scID/), and all the scripts to generate the figures shown in this manuscript are available at https://github.com/BatadaLab/scID_manuscript_figures.
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Weights from CEL−Seq Weights from CEL−Seq2 where " is the number of cells in cluster , is the total number of cells in the reference data, and ̃. * ∈ [0,1] is the normalized gene expression value of the -th gene in the -th cell in the reference data.
This definition of the weights (Eq. 2) is a solution to Fisher's linear discriminant analysis assuming diagonal covariance, where the separation between the two classes is defined as the ratio of the variance between the classes to the variance within the classes. Ideally, we would like to include the full covariance matrix in order to better capture the relationships among clusters. However, we have chosen to approximate the covariance matrix as diagonal for computational efficiency but also due to limitations posed by the nature of scRNA-seq data. When datasets have sparse coverage, the covariance matrix is not full rank and cannot be inverted. Additionally, when the list of genes is long, computing the full covariance matrix is error prone due to insufficient number of samples.
Choosing the weights in this way penalizes high variability and low mean expression in order to account for the following cases: a. When a positive marker is not expressed uniquely in the population, . " will increase, reducing the weight as it does not provide sufficient evidence of belonging to the cells of interest. b. When a positive marker is expressed only within a subpopulation of , .
" 6 will increase, reducing the weight so that a cell's score does not drop sharply when the gene is missing. This also accounts for genes with high dropout rate even though they might be specific and sensitive markers. c. Finally, non-discriminative genes will be down-weighted, as the numerator . " − . " O will be low.
Although we can compute these weights from the reference, computing them from the target data can lead to improved accuracy, due to adjustments to the data quality and cell type composition in the target data. However, to do this we need to select target cells that are likely equivalent to the reference cluster . The target cells (denoted as ) that express the $ " signature genes precisely and specifically and do not express the & " signature genes are selected as equivalent to the reference cluster by clustering the data in the differential precision-differential recall domain which we refer to as differential precision recall or DPR approach.
In general, precision of a cell expressing a set of genes is defined as the total number of expressed genes that belong to the given set divided by the total number of expressed genes and recall is defined as the number of expressed genes that belong to the set divided by the total number of genes in the set. So, for the set of positive markers ( $ " )
where $[\ : number of upregulated signature genes expressed $[ : total number of upregulated signature genes \ : total number of expressed genes A cell expressing all positive markers will have $ = 1 and a cell expressing only positive markers (and no other genes) will have $ = 1. Thus, cells equivalent to cluster will be in the first quadrant of the ( $ , $ ) space close to (1,1) and other cells not expressing the positive markers will be close to (0,0). To identify target cells equivalent to reference cluster , we have combined the precision and recall for positive and negative markers via a differential precision ( ) and differential recall ( ) metric as follows:
Thus, target cells equivalent to cluster will be close to (1,1), cells very different from cluster will be close to (-1,-1), and cells belonging to clusters that are similar to cluster and share markers will be around (0,0). This will help separate cells equivalent to cluster from cells belonging to very similar clusters that could be otherwise grouped together if we were only using the positive markers.
To select putative positive and negative training populations from the DP-DR space, we cluster the cells using different Gaussian finite mixture models (Scrucca, Fop et al., 2016 ) and select the model with the lowest Bayesian Information Criterion (BIC). The clusters with highest DP and/or DR are selected as candidate matching clusters. From the candidate clusters, we select as the one with the closest to (1,1) centroid as measured by Euclidean distance. All other candidate clusters are discarded from the training set and the remaining clusters are used as training non-matching clusters (`).
Analogous to computing the weights in the reference data, they can be computed from the target data using the training sets of cells ( and `) . where . a , . a represent the mean and standard deviation, respectively, of gene in the cluster and . a O , . a O represent the mean and standard deviation, respectively, of gene in the cluster `. Each term of the weight of gene is in turn calculated as follows: where a , a O are the number of cells in clusters and ` respectively.
The weights estimated from the target data reflect the cellular composition of the target data and quality (i.e. the distribution of dropout and dynamic range of gene expression) of the target data both of which influence the discriminatory power of the features.
Then, to identify target cells equivalent to reference cluster , we fit different finite mixtures of Gaussians on the score * " (Eq. 1) and assign cells that belong to the population with highest average score to reference cluster .
When the reference data contains clusters that are highly similar transcriptionally, the features from a cluster can be correlated with the features from another cluster which in turn lead scID to assign target cells to multiple reference classes. To resolve this, the scores of target cells * " is first z-score normalized and the ambiguous cell is assigned to the reference cluster with the highest normalized score over all other reference clusters it was assigned to.
